Katherine D. Crew

8.9k citations

181 papers · 6.0k indexed · 1 hit paper · h-index 36

Oncology top 0.5%
- Cancer Treatment and Pharmacology 30
- Global Cancer Incidence and Screening 29
- Cancer Risks and Factors 19
Complementary and alternative medicine top 0.5%
Cancer Research top 2%
- Breast Cancer Treatment Studies 23
Pulmonary and Respiratory Medicine top 2%
- Advanced Breast Cancer Therapies 12
Gastroenterology top 2%
Genetics
- BRCA gene mutations in cancer 37
- Estrogen and related hormone effects 21
- Nutrition, Genetics, and Disease 13

Co-authors: Alfred I. Neugut Dawn L. Hershman Heather Greenlee Lois Brafman Jillian L. Capodice Déborah Fuentes Danielle Awad George Raptis
Cited by: Oncology Complementary and alternative medicine Cancer Research
Partner nations: United States South Africa United Kingdom

In The Last Decade

Katherine D. Crew

171 papers receiving 5.8k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Katherine D. Crew

Since Specialization

Citations

This map shows the geographic impact of Katherine D. Crew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine D. Crew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine D. Crew more than expected).

Fields of papers citing papers by Katherine D. Crew

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine D. Crew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine D. Crew. The network helps show where Katherine D. Crew may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Katherine D. Crew, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Katherine D. Crew Line = papers co-authored together Katherine D. Crew links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The breast cancer genetic testing experience: probing the potential utility of an online decision aid in risk perception and decision making Anna Vaynrub,Brian Salazar,Yilin Eileen Feng,Harry West,Alissa Michel,Subiksha Umakanth,Katherine D. Crew,Rita Kukafka	2025	1
2	Continuous glucose monitoring to characterize hyperglycemia during chemotherapy for early stage breast cancer Sophie Ulene,Shikun Wang,Joshua R. Cook,Fiona M. McAuley,Margaux Wooster,Khadija Faheem,Andrew Varoli,Julia E. McGuinness,Neil Vasan,Meghna S. Trivedi,Katherine D. Crew,Erik Harden,Cynthia Law,Dawn L. Hershman,Melissa Accordino	2025	3
3	Predictors of trastuzumab-induced cardiotoxicity among racially and ethnically diverse patients with HER2-positive breast cancer Anna Vaynrub,Leila Mishalani,J. Raikhelkar,Katherine D. Crew	2024	0
4	Abstract PO1-10-04: Racial and Ethnic Disparities in Anthracycline and HER2-targeted Cardiotoxicity in Patients With Breast Cancer Using Global Longitudinal Strain Imaging Techniques Ying Wang,J. Raikhelkar,Rohit Raghunathan,Julia E. McGuinness,Neil Vasan,Meghna S. Trivedi,Kevin Kalinsky,Katherine D. Crew,Melissa Beauchemin,Jason D. Wright,Dawn L. Hershman,Melissa Accordino	2024	1
5	Pharmacist-Led Video Consultation to Identify and Mitigate Drug Interactions Among Patients Initiating Oral Anticancer Drugs Morgan RL Lichtenstein,Peter M. Campbell,Rohit Raghunathan,Melissa Beauchemin,Elena B. Elkin,Katherine D. Crew,Melissa Accordino,Cindy Ippoliti,Michelle Hwang,Rachel Abramova,Erik Harden,Paige Kelly,Nicole Collins,Khadija Faheem,Jason D. Wright,Dawn L. Hershman	2024	0
6	Time to Cancer Treatment and Chemotherapy Relative Dose Intensity for Patients With Breast Cancer Living With HIV Daniel S. O’Neil,Yehoda M. Martei,Katherine D. Crew,Brenda S. Castillo,Philippos Apolinário Costa,Tristan Lim,Alissa Michel,Elizabeth S. Rubin,Neha Goel,Judith Hurley,Gilberto Lopes,Michael H. Antoni	2023	1
7	Breast cancer treatment receipt and the role of financial stress, health literacy, and numeracy among diverse breast cancer survivors Ashley Odai-Afotey,Ruth Lederman,Naomi Y. Ko,Haley Gagnon,Tsion Fikre,Daniel A. Gundersen,Anna Revette,Dawn L. Hershman,Katherine D. Crew,Nancy L. Keating,Rachel A. Freedman	2023	7
8	Breast cancer knowledge and understanding treatment rationales among diverse breast cancer survivors Rachel A. Freedman,Naomi Y. Ko,Ruth Lederman,Haley Gagnon,Tsion Fikre,Daniel A. Gundersen,Anna Revette,Ashley Odai-Afotey,Olga Kantor,Dawn L. Hershman,Katherine D. Crew,Nancy L. Keating	2022	8
9	Lessons from the Failure to Complete a Trial of Denosumab in Women With a Pathogenic BRCA1/2 Variant Scheduling Risk-Reducing Salpingo-Oophorectomy Meghna S. Trivedi,Nadir Arber,Eitan Friedman,Judy E. Garber,Kevin Holcomb,Neil S. Horowitz,Jason D. Wright,J. Jack Lee,Lana A. Vornik,Saba Abutaseh,Tawana Castile,Edward R. Sauter,Eileen Dimond,Brandy M. Heckman‐Stoddard,Margaret G. House,Goli Samimi,Powel H. Brown,Katherine D. Crew	2022	3
10	Predictors of Pain Reduction in Trials of Interventions for Aromatase Inhibitor–Associated Musculoskeletal Symptoms N. Lynn Henry,Joseph M. Unger,Cathee Till,Katherine D. Crew,Michael Fisch,Dawn L. Hershman	2021	2
11	Care Delivery Impact of the COVID-19 Pandemic on Breast Cancer Care Tejus Satish,Rohit Raghunathan,Jake G. Prigoff,Jason D. Wright,Grace Clarke Hillyer,Meghna S. Trivedi,Kevin Kalinsky,Katherine D. Crew,Dawn L. Hershman,Melissa Accordino	2021	39
12	Association between nonadherence to cardiovascular risk factor medications after breast cancer diagnosis and incidence of cardiac events Dawn L. Hershman,Melissa Accordino,Sherry Shen,Donna Buono,Katherine D. Crew,Kevin Kalinsky,Meghna S. Trivedi,Chin Hur,Jianhua Hu,Joseph M. Unger,Jason D. Wright	2020	13
13	Randomized Double-Blind Placebo-Controlled Biomarker Modulation Study of Vitamin D Supplementation in Premenopausal Women at High Risk for Breast Cancer (SWOG S0812) Katherine D. Crew,Garnet L. Anderson,Dawn L. Hershman,Mary Beth Terry,Parisa Tehranifar,Danika L. Lew,Monica Yee,Eric Brown,Sebastien S. Kairouz,Nafisa Kuwajerwala,Therese B. Bevers,John E. Doster,Corrine Zarwan,Laura Kruper,Lori M. Minasian,Leslie G. Ford,Banu Arun,Marian L. Neuhouser,Gary E. Goodman,Powel H. Brown	2019	16
14	Factors Associated with False Positive Results on Screening Mammography in a Population of Predominantly Hispanic Women Julia E. McGuinness,William Ueng,Meghna S. Trivedi,Hae Seung Yi,Raven David,Alejandro Vanegas,Jennifer Vargas,Rossy Sandoval,Rita Kukafka,Katherine D. Crew	2018	17
15	Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927) Sherry Shen,Joseph M. Unger,Katherine D. Crew,Cathee Till,Heather Greenlee,Julie R. Gralow,Shaker R. Dakhil,Lori M. Minasian,James L. Wade,Michael Fisch,N. Lynn Henry,Dawn L. Hershman	2018	33
16	Diffuse optical tomography changes correlate with residual cancer burden after neoadjuvant chemotherapy in breast cancer patients Emerson A. Lim,Jacqueline Gunther,Hyun Koo Kim,Molly Flexman,Hanina Hibshoosh,Katherine D. Crew,Bret Taback,Jessica Campbell,Kevin Kalinsky,Andreas H. Hielscher,Dawn L. Hershman	2017	13
17	¡Cocinar Para Su Salud!: Randomized Controlled Trial of a Culturally Based Dietary Intervention among Hispanic Breast Cancer Survivors Heather Greenlee,Ann Ogden Gaffney,A. Corina Aycinena,Pam Koch,Isobel R. Contento,Wahida Karmally,John M. Richardson,Emerson A. Lim,Wei‐Yann Tsai,Katherine D. Crew,Matthew Maurer,Kevin Kalinsky,Dawn L. Hershman	2015	58
18	¡Cocinar Para Su Salud!: Randomized Controlled Trial of a Culturally Based Dietary Intervention among Hispanic Breast Cancer Survivors Heather Greenlee,Ann Ogden Gaffney,A. Corina Aycinena,Pam Koch,Isobel R. Contento,Wahida Karmally,John M. Richardson,Emerson A. Lim,Wei‐Yann Tsai,Katherine D. Crew,Matthew Maurer,Kevin Kalinsky,Dawn L. Hershman	2015	20
19	Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy Dawn L. Hershman,Joseph M. Unger,Katherine D. Crew,Lori M. Minasian,Danielle Awad,Carol M. Moinpour,Lisa Hansen,Danika L. Lew,Heather Greenlee,Louis Fehrenbacher,James L. Wade,Siu‐Fun Wong,Gabriel N. Hortobágyi,Frank L. Meyskens,Kathy S. Albain	2013	145
20	Phase IB Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Women with Hormone Receptor–Negative Breast Cancer Katherine D. Crew,Powel H. Brown,Heather Greenlee,Therese B. Bevers,Banu Arun,Clifford A. Hudis,Heather L. McArthur,Jenny C. Chang,Mothaffar F. Rimawi,Lana A. Vornik,Terri L. Cornelison,Antai Wang,Hanina Hibshoosh,Aqeel Ahmed,Mary Beth Terry,Regina M. Santella,Scott M. Lippman,Dawn L. Hershman	2012	76

About Katherine D. Crew

Katherine D. Crew is a scholar working on Oncology, Cancer Research and Genetics, having authored 181 papers that have together received 6.0k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (37 papers), Cancer Treatment and Pharmacology (30 papers), Global Cancer Incidence and Screening (29 papers), Breast Cancer Treatment Studies (23 papers), Estrogen and related hormone effects (21 papers), Cancer Risks and Factors (19 papers), Nutrition, Genetics, and Disease (13 papers) and Advanced Breast Cancer Therapies (12 papers). The work is most often cited by research in Oncology (2.8k citations), Complementary and alternative medicine (448 citations) and Cancer Research (813 citations). Katherine D. Crew has collaborated with scholars based in United States, South Africa and United Kingdom. Frequent co-authors include Alfred I. Neugut, Dawn L. Hershman, Heather Greenlee, Lois Brafman, Jillian L. Capodice, Déborah Fuentes, Danielle Awad, George Raptis, Serge Cremers and Elizabeth Shane.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact